Repeated Alpha1H treatments creates long-term protection against bladder tumor growth in mice
Today Hamlet Pharma is proud to announce new treatment advances in an experimental model of bladder cancer.A potent treatment effect of Alpha1H has previously been reported in mice with bladder cancer. We now show that continued treatment can provide long-term protection as well. Repeated treatment prevented tumor growth and the bladders remained similar to the control group without tumors. In contrast, mice treated with placebo showed rapid tumor progression and severe disease after 12 days. The first round of Alpha1H treatment prevented tumor development for 4 weeks and long-term